CN104435053A - Composition with effect of preventing multiple infections and preparation method of composition - Google Patents
Composition with effect of preventing multiple infections and preparation method of composition Download PDFInfo
- Publication number
- CN104435053A CN104435053A CN201410637677.6A CN201410637677A CN104435053A CN 104435053 A CN104435053 A CN 104435053A CN 201410637677 A CN201410637677 A CN 201410637677A CN 104435053 A CN104435053 A CN 104435053A
- Authority
- CN
- China
- Prior art keywords
- composition
- compositions
- hot water
- effect
- active component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title claims abstract description 42
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims description 8
- 239000010231 banlangen Substances 0.000 claims description 32
- 241000628997 Flos Species 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000000284 extract Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 7
- 239000002671 adjuvant Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 238000013467 fragmentation Methods 0.000 claims description 5
- 238000006062 fragmentation reaction Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 238000003809 water extraction Methods 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 150000002772 monosaccharides Chemical class 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 150000002016 disaccharides Chemical class 0.000 claims description 2
- 206010061218 Inflammation Diseases 0.000 abstract description 11
- 244000269722 Thea sinensis Species 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 235000009508 confectionery Nutrition 0.000 abstract description 10
- 230000004054 inflammatory process Effects 0.000 abstract description 10
- 206010022000 influenza Diseases 0.000 abstract description 9
- 241000700605 Viruses Species 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 206010037660 Pyrexia Diseases 0.000 abstract description 6
- 230000002924 anti-infective effect Effects 0.000 abstract description 6
- 230000036737 immune function Effects 0.000 abstract description 6
- 230000002147 killing effect Effects 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 5
- 230000000840 anti-viral effect Effects 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 3
- 201000005505 Measles Diseases 0.000 abstract description 3
- 208000005647 Mumps Diseases 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 208000010805 mumps infectious disease Diseases 0.000 abstract description 3
- 230000036407 pain Effects 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 3
- 230000003612 virological effect Effects 0.000 abstract description 3
- 208000004880 Polyuria Diseases 0.000 abstract description 2
- 244000052616 bacterial pathogen Species 0.000 abstract description 2
- 230000035619 diuresis Effects 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 2
- 241000245665 Taraxacum Species 0.000 abstract 2
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000001914 calming effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 16
- 239000003814 drug Substances 0.000 description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 8
- 239000011701 zinc Substances 0.000 description 8
- 229910052725 zinc Inorganic materials 0.000 description 8
- 239000004599 antimicrobial Substances 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 6
- 229930003268 Vitamin C Natural products 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 235000013616 tea Nutrition 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- COHYTHOBJLSHDF-UHFFFAOYSA-N Indigo Chemical compound N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 229910052732 germanium Inorganic materials 0.000 description 4
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- 239000011669 selenium Substances 0.000 description 4
- 229910052711 selenium Inorganic materials 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 241001062009 Indigofera Species 0.000 description 3
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 3
- 241000334154 Isatis tinctoria Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 208000036142 Viral infection Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000000721 bacterilogical effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000007123 defense Effects 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000004792 oxidative damage Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010020601 Hyperchlorhydria Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 241001092459 Rubus Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 206010001093 acute tonsillitis Diseases 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- -1 arsenic aluminum Chemical compound 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229940093797 bioflavonoids Drugs 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 229940097275 indigo Drugs 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000003265 lymphadenitis Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002510 pyrogen Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 235000014138 Caesalpinia decapetala Nutrition 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 108010001394 Disaccharidases Proteins 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 102100025087 Insulin receptor substrate 1 Human genes 0.000 description 1
- 101710201824 Insulin receptor substrate 1 Proteins 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000334160 Isatis Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 206010024238 Leptospirosis Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000243684 Lumbricus Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241000382362 Persicaria tinctoria Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- 241000257673 Strobilanthes cusia Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000010641 Tooth disease Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 102100023132 Transcription factor Jun Human genes 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000004665 defense response Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- COHYTHOBJLSHDF-BUHFOSPRSA-N indigo dye Chemical compound N\1C2=CC=CC=C2C(=O)C/1=C1/C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-BUHFOSPRSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010189 intracellular transport Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000037345 metabolism of vitamins Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 230000009822 protein phosphorylation Effects 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000002207 thermal evaporation Methods 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a composition with an effect of preventing multiple infections. The composition comprises the active ingredients of indigowoad root, dandelion, honeysuckle flower and sweet tea in the weight ratio of (5-20):(2-10):(1-5):(1-2). The composition provided by the invention combines indigowoad root, dandelion, honeysuckle flower and sweet tea for using together. On the one aspect, through the effects of clearing away heat and toxic materials, relieving pain, relieving fever, resisting inflammation, calming mind, promoting blood circulation, removing blood stasis, inducing diuresis, eliminating swelling and the like, the immune function of a human body is regulated, the anti-infection ability of the human body is strengthened and the inflammation is eliminated. On the other aspect, the anti-infection effect is realized by direct sterilization, bacteriostasis and anti-viral action, so that the composition is effective for viral influenza, measles, mumps, cold and influenza and can also be used for treating the inflammation caused by bacteria and part of other microbial infections. The composition can treat both manifestation and root cause and has obvious effects on inhibiting and killing a variety of viruses and pathogenic bacteria. The invention further provides a method for preparing the composition with the effect of preventing multiple infections.
Description
Technical field
The present invention relates to viral infection and bacteriological infection, be specifically related to the composition and method of making the same with anti-multi-infection effect.
Background technology
Infection causes inflammation, thus makes the biological tissue with vascular system to damage factor generation defense reaction.
Infection has viral infection and bacteriological infection.Antimicrobial drug has suppression or killing action to antibacterial, and it comprises the antibacterials of antibiotic and synthetic.Antimicrobial drug is only applicable to the inflammation caused by antibacterial and other microorganisms of part, gives antimicrobial drug treatment do harm rather than good patients such as viral influenza, measles, parotitis, cold, influenzas.Antimicrobial drug is the microorganism for causing inflammation, and is killing microorganisms.Do not have the effect of prevention infection, on the contrary, life-time service antimicrobial drug can cause bacterial resistance.The abuse of antimicrobial drug can impel generation fastbacteria on the one hand, and these medicines enter after in human body and will constrain and kill flora useful in human body on the other hand, cause dysbacteriosis, cause resistance to decline.In addition the system of defense of human body can be made to can not get taking exercise, and defense response weakens, and defense reaction (namely produce inflammation, cry inflammation again) is slight, once the factor that sustains damage is attacked, health will collapse very soon.
Utilize Chinese medicine or meet Chinese traditional medicine principle food reply infect (comprising viral infection and bacteriological infection), a kind of good method of promoting what is beneficial and abolish what is harmful of can yet be regarded as.Traditional Chinese Medicine experts analysis is pointed out, Chinese medicine all has good therapeutical effect to multi-infection disease, its cure mechanism, have plenty of by directly sterilizing, antibacterial, antiviral and play anti-infectious function, more then be regulate human immunologic function by the effect such as clearing away heat-damp and promoting diuresis, blood circulation promoting and blood stasis dispelling, removing toxic substances and promoting subsidence of swelling, strengthen the anti-infection ability of human body.
Summary of the invention
In order to solve the problem of antimicrobial drug abuse, giving full play to Chinese medicine and meeting the effect of food in resistance infection of Chinese traditional medicine principle, the invention provides a kind of compositions with anti-multi-infection effect.
The compositions with anti-multi-infection effect of the present invention, its active component comprises Radix Isatidis, Herba Taraxaci, Flos Lonicerae and Folium hydrangeae strigosae, and the weight ratio of Radix Isatidis/Herba Taraxaci/Flos Lonicerae/Folium hydrangeae strigosae is 5 ~ 20/2 ~ 10/1 ~ 5/1 ~ 2.
Further, the gross weight of active component accounts for more than 10% of whole composition.
Further, the gross weight of active component accounts for more than 30% of whole composition.
Implement as one, also comprise appropriate adjuvant, but do not comprise monosaccharide, disaccharide.
The form of compositions of the present invention comprises: active component mixture of raw materials, and granule, liquid, capsule, sheet or ball that active component extract is made.
In the present invention, active component refers to the plant playing anti-multi-infection effect containing effective ingredient, comprises the root of plant, stem, Ye Heguo.
Adjuvant refers to the adjuvant entered in product.As be conducive to the water etc. in the dextrin of solid product molding, fluid product.
Refer in right amount and meet product specification and the amount of adding.As being deployed into the water yield required for certain concentration, or be convenient to requirement making product pelletize etc.
The form of compositions refers to the form of product, and such as raw material fragmentation mixes pack afterwards and becomes the product form that teabag is exactly a kind of mixture of raw materials.
The form of compositions of the present invention is from product form.As from commodity classification, compositions of the present invention can be food, beverage, health product, also can be medicine.
Radix Isatidis (conventional another name: indigo-blue, Isatis indigotica Fort (Indigofera tinctoria L, Baphicanthus cusia (nees) Brem. Polygonum tinctorium Ait) root, Radix Clerodenri Cyrtophylli) Isatis indigotica Fort. that has another name called, mountain indigo plant, great Lan root, rhizoma et radix baphicacanthis, Lan Longgen, Lumbricus root, greatly indigo etc., be a kind of Chinese crude drug.All produce all over China.Radix Isatidis is divided into northern Radix Isatidis and Rhizoma Et Radix Baphicacanthis Cusiae, and northern Radix Isatidis source is the root of cruciferae isatis (Isatis tinctoria L.); Rhizoma Et Radix Baphicacanthis Cusiae is rhizome and the root of acanthaceous vegetable acanthaceous indigo (Baphicacanthus cusia (Nees) Brem.).
In efficacy effect, Radix Isatidis bitter in the mouth, cold in nature, there is the effects such as heat-clearing and toxic substances removing, removing heat from blood, speckle removing, sore-throat relieving, be mainly used in the treatment of the disease such as epidemic febrile disease heating, headache, laryngalgia, macule, mumps, carbuncle sore tumefacting virus, cure mainly pharyngolaryngitis, acute tonsillitis, influenza, mumps, acute infectious hepatitis etc.It has inhibitory action to cold virus.Radix Isatidis has external broad-spectrum antibacterial action (comprising dysentery antibacterial, salmonella bacteria, hemolytic rope-forming bacteria), be anti-inflammation, pain relieving, the Chinese traditional herbs of bringing down a fever.
Containing multiple antiviral substance in Radix Isatidis, there are stronger suppression and killing action to cold virus, mumps virus, hepatitis virus and epidemic encephalitis virus etc.Radix Isatidis and Rhizoma Osmundae, Flos Lonicerae, Flos Chrysanthemi Indici etc. share, and are used for the treatment of some infectious disease and febrile disease.
Radix Isatidis clinically clearing away heat and cooling blood, antiviral antibacterial action is obvious, and consumption is large, can be rated as Chinese patent medicine.Result of study shows, Radix Isatidis has in significant purged body the pyrogen effect that body temperature can be caused to raise, and has been separated and obtains this active substance.The effect of bringing down a fever of Radix Isatidis namely by killing the pathogen such as virus and bacteria in body, remove and cause the factors such as the peroxy radical of fever and pyrogen to realize.When low grade fever, take the Chinese patent medicines such as Radix Isatidis, not only can effectively bring down a fever, meanwhile, the rehabilitation of health and the enhancing of immunity resistance can also be promoted.Early stage application, coordinates anti symptom treatment simultaneously, greatly can improve therapeutic effect.
Although Radix Isatidis has above-mentioned many good effects, if the time also had has been grown, the quantity of eating is many, will amass " medicine " and become disease, lead to future trouble.The case causing children's's anaphylaxis, digestive system and hemopoietic system to damage in clinical middle use Radix Isatidis granules is of common occurrence.
Folium hydrangeae strigosae (formal name used at school: Rubus Suatrssimus S.Lee, English name Sweet tea) is Rosaceae rubus, and having another name called sweet leaf Fructus Rubi corchorifolii Immaturus, is perennial wait-a-bit, and Guangxi is among the people is often used as tea-drinking, and leaf taste is sweet, therefore named Folium hydrangeae strigosae.Main product in Guilin, Liuzhou, the area such as Wuzhou, be Endemic Plants From Guangxi.Folium hydrangeae strigosae is cool in nature, sweet in the mouth is flat, has the effects such as heat clearing away, moistening lung and nourishing throat, expelling phlegm for arresting cough.Folium hydrangeae strigosae have blood pressure lowering, blood sugar lowering, enhances metabolism, treats the effects such as hyperchlorhydria.Folium hydrangeae strigosae element or the low-calorie non-sugar sweetener of a kind of high sugariness, sugariness is 300 times of sucrose, and calorific value is only 1% of sucrose, can be used as the succedaneum of glucide and sucrose, for the industry such as food, medicine.The patients such as cardiovascular, obesity, diabetes are all drinkable.Effect that Folium hydrangeae strigosae possesses common green tea also has the drug effects such as prevention and cure of cardiovascular disease, prevention of stroke, protective effect on cancer risk, prophylaxis of teeth disease outward simultaneously, there is heat-clearing and toxic substances removing, moistening the lung and resolving phlegm cough-relieving, cancer-resisting, antiallergic, anti-fat lipid-lowering and blood-pressure-lowing, reduction cholesterolemia, suppress and delay sclerosis of blood vessels, prevent and treat numerous health care such as coronary heart disease and diabetes, can melanin be decomposed, suppress the formation of black speck and chloasma.Folium hydrangeae strigosae also has good analgesia, antiinflammatory, sedation.
In Folium hydrangeae strigosae except the effective ingredient such as the antioxidative tea polyphenols containing common green tea, also be rich in 18 seed amino acids, every 100 grams of dry products containing total amino acid content 331.54 milligrams, be particularly rich in Folium hydrangeae strigosae human body necessary, human body can not generate, 8 seed amino acids that can only absorb from food.Folium hydrangeae strigosae is containing abundant nutrient substance and the necessary trace element of human body, mainly contain calcium 0.84%, zinc 105.5mg/kg, germanium 5.5 μ g/kg, selenium 17.94 μ g/kg, and the multiple element such as potassium, magnesium, phosphorus, ferrum, sodium, copper, chromium, strontium, lithium, not containing noxious substances such as arsenic aluminum, except above-mentioned contained trace element, be also rich in vitamin C, B
1, B
2, B
3, superoxide dismutase, in fresh and sweet tea, ascorbic content is up to 115mg/100g.Selenium can eliminate harmful free radical, changes the metabolism direction of carcinogen, reduces the oxidative damage of human body cell and cell membrane component, improves body resistivity.Germanium can strengthen erythrocytic band oxygen ability, thus ensures the oxygen-supplying amount of body, is conducive to metabolic carrying out.Bioflavonoids can strengthen blood capillary, antioxidation, blood pressure lowering.
Folium hydrangeae strigosae plays the effect improving immunity of organisms (resistivity) from the following aspects:
(1) selenium in Folium hydrangeae strigosae can eliminate harmful free radical, changes the metabolism direction of carcinogen, reduces the oxidative damage of human body cell and cell membrane component, improves body resistivity, thus can delay the life-span of people;
(2) germanium in Folium hydrangeae strigosae can strengthen erythrocytic band oxygen ability, thus ensures the oxygen-supplying amount of body, is conducive to metabolic carrying out.
(3) Folium hydrangeae strigosae is containing zinc.Zinc is the indispensable trace element of human body, and in human body, many kinds of enzymes must have zinc to participate in competence exertion effect, and zinc is very important to adjustment immunologic function.In addition, zinc can also infection.Take in the zinc of 50 ~ 100 milligrams every day, just can flu-prevention.Zinc is the constituent of a lot of important enzyme in human body, has catalytic action to vital movement, improves autoimmunity, and participates in the metabolism of vitamin A.
(4) Folium hydrangeae strigosae is containing vitamin C.Vitamin can strengthen body immunity, and vitamin C is that human body is indispensable, and it can reduce capillary permeability, makes it to become a barrier, stops cell entry tissue, protection biological organs.Collagen protein is a kind of extracellular protein, and it twists into spiral fibrous proteins by 3 peptide chains, and collagen protein is the most rich in protein of people's in-vivo content, accounts for more than 30% of whole body gross protein.Be rich in the aminoacid such as glycine, proline, hydroxyproline that human body needs.Collagen protein is most important ingredient in extracellular matrix.The synthesis of collagen protein needs vitamin C to participate in, so VC lacks, collagen protein just can not normally synthesize.VC can promote the synthesis of human collagen albumen, and has stronger reproducibility.The generation of energy check melanin.Meanwhile, all right vat black pigment, makes it desalinate.Skin and muscles are fair in order.Anti-aging effects is remarkable.
(5) Folium hydrangeae strigosae is containing flavone and superoxide dismutase.They all have Scavenging ability.Free radical is called as the source of ten thousand diseases, is chemically called " free radical ", is the atomic group containing a unpaired electron.Owing to lacking electronics, therefore free radical just captures an electronics of other materials everywhere, makes oneself to form stable material.In chemistry, this phenomenon is called " oxidation ".Reactive oxygen free radical is by activation c-Jun kinases, and NF-kappaB etc., make insulin receptor substrate (IRS) protein phosphorylation, accelerate the degraded of IRS-1, cause insulin resistant.The hyperfunction PKC that causes of polyhydric alcohol metabolism activates in addition, and Advanced glycation end products increases, and protein function changes, and intracellular transport obstacle, trigger cell apoptosis etc., cause diabetes nerve dysfunction.Remove unnecessary free radical, reduce oxidized cell, recover normal cell function, fall three fat, blood sugar lowering, resisting fatigue, thus can immunity of organisms be improved.
(6) Folium hydrangeae strigosae is containing aminoacid.Particularly 8 kinds of essential amino acids.
(7) tea polyphenols that Folium hydrangeae strigosae contains has obvious antioxidation.
Herba Taraxaci is the whole herb with root of feverfew Herba Taraxaci, containing taraxasterol, choline, inulin and fruit acid etc.; Its decoct has resisting pathogenic microbes effect; Have again protect the liver, the effect of function of gallbladder promoting and raising immune function of human body.The traditional Chinese medical science is thought, it is cold in nature, sweet in the mouth, hardship, function heat-clearing and toxic substances removing, and dispersing swelling and dissipating binds, is applicable to acute mastitis, and lymphadenitis carries adenitis on the shoulder, gastritis, hepatitis, cholecystitis, urinary tract infection etc.Experiment proves that Herba Taraxaci decocting liquid has broad-spectrum antiseptic and obvious biocidal efficacies.It all has significant curative effect to acute tonsillitis, conjunctivitis, urinary tract infection, mastitis, tracheitis, gastritis etc.
Flos Lonicerae is the alabastrum of caprifoliaceae plant Radix Ophiopogonis, containing chlorogenic acid, and inositol, flavones ingredient etc.; Pharmacological testing proves: Flos Lonicerae has antiinflammatory and refrigeration function, and infected by influenza and various pathogens, skin pathomycete have inhibitory action, reflect the heat-clearing toxin-expelling functions of Flos Lonicerae.The traditional Chinese medical science is thought, it is cold in nature, sweet in the mouth, function heat clearing away, removing toxic substances, is applicable to epidemic febrile disease heating, toxic-heat and blood stasis, the disease of the hyperactivity of toxic heat such as skin ulcer, carbuncle, furuncle and phyma.Flos Lonicerae cures mainly upper respiratory tract infection, pneumonia, pulmonary abscess, acute appendicitis, leptospirosis, bacillary dysentery, furuncle, carbuncle, erysipelas, uterine erosion etc.
Radix Isatidis, Herba Taraxaci, Flos Lonicerae and Folium hydrangeae strigosae are used in combination by the present invention, on the one hand by heat-clearing and toxic substances removing, pain relieving, bring down a fever, antiinflammatory, calmness, blood circulation promoting and blood stasis dispelling, dampness removing, the effect such as detumescence regulate human immunologic function, strengthen the anti-infection ability of human body, diminish inflammation.On the other hand by directly sterilization, antibacterial, antiviral and play anti-infectious function, effective to viral influenza, measles, parotitis, cold, influenza, also can treat the inflammation that antibacterial and other infected by microbes of part cause.Not only take stopgap measures but also effect a permanent cure, and have obvious inhibitory or killing effect to multiple virus and pathogenic bacteria.
And the present invention utilizes the sweet taste of Folium hydrangeae strigosae to cover the bitterness of Radix Isatidis, does not use monosaccharide and disaccharidase, compositions of the present invention is made also to be suitable for diabetics.The antiallergic of Folium hydrangeae strigosae is utilized to cause anaphylaxis to what resist Radix Isatidis.Utilize Folium hydrangeae strigosae can improve the function of human body resistivity to make up the defect that Radix Isatidis may cause the decline of immune function of human body.Folium hydrangeae strigosae is utilized to treat the function of hyperchlorhydria to prevent and treat Radix Isatidis damage digestive tract.Utilize the selenium in Folium hydrangeae strigosae to eliminate harmful free radical, reduce the oxidative damage of human body cell and cell membrane component, and germanium can strengthen erythrocytic band oxygen ability, ensure the oxygen-supplying amount of body, be conducive to metabolic carrying out, can the effects such as blood capillary be strengthened with bioflavonoids, prevent Radix Isatidis to the infringement of hemopoietic system.
The present invention also provides a kind of method preparing the compositions with anti-multi-infection effect.
The described preparation method with the compositions of anti-multi-infection effect, comprises following step:
(1) airtight extraction pot is put into together by after active component fragmentation;
(2) hot water extraction;
(3) extracting solution is condensed into extractum;
(4) (3) gained is mixed with adjuvant, granulates;
(5) dry;
(6) interior subpackage and outer package.
In step (2), hot water temperature is 50 ~ 90 degree; Extract 3 ~ 5 times, be 3 ~ 10 times of L/kg of extract weight with hot water amount, each time is 1 ~ 3 hour at every turn; Hot water comprises the hot water that adds or is heated at extraction pot by cold water and obtain.
Step (2) described hot water temperature is 50 ~ 60 degree.
In step (3), temperature is no more than 60 degree, vacuum concentration; In step (4), granulation particle diameter be 0.1 ~ 2mm in step (5), vacuum drying is to product moisture 0.1 ~ 5%.
Said method is the method that preparation has the compositions extract particles of anti-multi-infection effect.The preparation method of a kind of form of the compositions that just the present invention relates to.
In production method, meet light, heat and oxygen because of various effective ingredient and easily decompose, lose effect and effect.And sweet tea polyphenols has obvious antioxidant effect, be with by various material together hot water extraction, can loss of effective components be reduced.The present invention uses airtight extraction equipment, can effectively prevent vitamin C thermo-labile and evaporate, the vitamin C with thermal evaporation can be flowed back to water droplet.
Sweet tea polyphenols yet stores product and plays the rotten effect of antioxidation in addition.Thus do not need in product of the present invention to add any antiseptic.
In fact, the compositions with anti-multi-infection effect of the present invention, by the technical scheme of existing various maturations, can be prepared into various forms.
Detailed description of the invention
Embodiment 1
Be 20/10/5/1 batching by the weight ratio of Radix Isatidis/Herba Taraxaci/Flos Lonicerae/Folium hydrangeae strigosae.
(1) Radix Isatidis, Herba Taraxaci, Flos Lonicerae are put into airtight extraction pot together with after Folium hydrangeae strigosae fragmentation;
(2) hot water extraction; Hot water temperature is 60 degree; Extract 3 times, be 10 times of L/kg of extract weight with hot water amount, each time is 2 hours at every turn.
(3) extracting solution is condensed into extractum; Temperature 60 degree, vacuum concentration.
(4) (3) gained is mixed with dextrin, granulates; Granulation particle diameter is 1mm.
(5) dry; Vacuum drying is to product moisture 5%.
(6) interior subpackage and outer package.
Embodiment 2
Be 10/10/5/1 batching by the weight ratio of Radix Isatidis/Herba Taraxaci/Flos Lonicerae/Folium hydrangeae strigosae.
All the other are identical with embodiment 1.
Embodiment 3
Be 5/10/5/1 batching by the weight ratio of Radix Isatidis/Herba Taraxaci/Flos Lonicerae/Folium hydrangeae strigosae.
All the other are identical with embodiment 1.
Embodiment 4
Be 10/2/5/1 batching by the weight ratio of Radix Isatidis/Herba Taraxaci/Flos Lonicerae/Folium hydrangeae strigosae.
When preparing product, step (1) (2) (3) with embodiment 1, afterwards,
(4) (3) gained is mixed with dextrin.
(5) dry; Vacuum drying is to product moisture 5%.
(6) then according to after existing conventional techniques tabletting, interior subpackage and outer package is carried out.
Embodiment 5
Be 20/2/1/1 batching by the weight ratio of Radix Isatidis/Herba Taraxaci/Flos Lonicerae/Folium hydrangeae strigosae.
(1) Radix Isatidis, Herba Taraxaci, Flos Lonicerae are put into airtight extraction pot together with after Folium hydrangeae strigosae fragmentation;
(2) hot water extraction; Hot water temperature is 60 degree; Extract 3 times, be 10 times of L/kg of extract weight with hot water amount, each time is 2 hours at every turn.
Then liquid beverage or oral liquid is made according to existing conventional techniques.
Embodiment 6
Be 5/2/1/2 batching by the weight ratio of Radix Isatidis/Herba Taraxaci/Flos Lonicerae/Folium hydrangeae strigosae.
All the other are identical with embodiment 5.
Claims (9)
1. have the compositions of anti-multi-infection effect, its active component comprises Radix Isatidis, Herba Taraxaci, Flos Lonicerae and Folium hydrangeae strigosae, and the weight ratio of Radix Isatidis/Herba Taraxaci/Flos Lonicerae/Folium hydrangeae strigosae is 5 ~ 20/2 ~ 10/1 ~ 5/1 ~ 2.
2. the compositions with anti-multi-infection effect according to claim 1, is characterized in that the gross weight of active component accounts for more than 10% of whole composition.
3. the compositions with anti-multi-infection effect according to claim 1, is characterized in that the gross weight of active component accounts for more than 30% of whole composition.
4. the compositions with anti-multi-infection effect according to claim 1, is characterized in that: also comprise appropriate adjuvant, but does not comprise monosaccharide, disaccharide.
5. the compositions with anti-multi-infection effect according to claim 1, is characterized in that: the form of compositions comprises: active component mixture of raw materials, and granule, liquid, capsule, sheet or ball that active component extract is made.
6. the preparation method with the compositions of anti-multi-infection effect described in any one of Claims 1 to 5, comprises following step:
(1) airtight extraction pot is put into together by after active component fragmentation;
(2) hot water extraction;
(3) extracting solution is condensed into extractum;
(4) (3) gained is mixed with adjuvant, granulates;
(5) dry;
(6) interior subpackage and outer package.
7. preparation method according to claim 6, is characterized in that: in step (2), and hot water temperature is 50 ~ 90 degree; Extract 3 ~ 5 times, be 3 ~ 10 times of L/kg of extract weight with hot water amount, each time is 1 ~ 3 hour at every turn; Hot water comprises the hot water that adds or is heated at extraction pot by cold water and obtain.
8. the preparation method according to claim 6 or 7, is characterized in that: step (2) described hot water temperature is 50 ~ 60 degree.
9. preparation method according to claim 6, is characterized in that: in step (3), temperature is no more than 60 degree, vacuum concentration; In step (4), granulation particle diameter is 0.1 ~ 2mm; In step (5), vacuum drying is to product moisture 0.1 ~ 5%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410637677.6A CN104435053A (en) | 2014-11-13 | 2014-11-13 | Composition with effect of preventing multiple infections and preparation method of composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410637677.6A CN104435053A (en) | 2014-11-13 | 2014-11-13 | Composition with effect of preventing multiple infections and preparation method of composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104435053A true CN104435053A (en) | 2015-03-25 |
Family
ID=52882315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410637677.6A Pending CN104435053A (en) | 2014-11-13 | 2014-11-13 | Composition with effect of preventing multiple infections and preparation method of composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104435053A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113350393A (en) * | 2020-03-06 | 2021-09-07 | 湖南诺泽生物科技有限公司 | Traditional Chinese medicine composition and feed composition containing same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101002819A (en) * | 2006-01-16 | 2007-07-25 | 陈茜 | Compound dandelion dripping pills and its preparing method |
CN102669365A (en) * | 2012-05-09 | 2012-09-19 | 王玉兰 | Dandelion tea capable of clearing heat and purging fire |
-
2014
- 2014-11-13 CN CN201410637677.6A patent/CN104435053A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101002819A (en) * | 2006-01-16 | 2007-07-25 | 陈茜 | Compound dandelion dripping pills and its preparing method |
CN102669365A (en) * | 2012-05-09 | 2012-09-19 | 王玉兰 | Dandelion tea capable of clearing heat and purging fire |
Non-Patent Citations (1)
Title |
---|
韩碧群等: "甜茶的应用历史与研究现状", 《中国现代中药》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113350393A (en) * | 2020-03-06 | 2021-09-07 | 湖南诺泽生物科技有限公司 | Traditional Chinese medicine composition and feed composition containing same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102846866B (en) | Chinese medicine composition for prevention and control of porcine circovirus disease and preparation method thereof | |
CN103585433B (en) | Traditional Chinese medicine composition for treating oral ulcer | |
CN102836290A (en) | Chinese herbal tea for preventing and treating flu | |
CN104208245B (en) | Tinea manus and pedis Traditional Chinese medicine medicated bath and preparation method | |
CN104096154A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
CN111803608A (en) | A Chinese medicinal composition with antiviral effect | |
CN106389587A (en) | Clearing and moistening health care scented tea and preparation process thereof | |
CN107737229A (en) | Prevent and treat Chinese herbal feed additive of swine flu and preparation method thereof | |
CN106421037A (en) | Traditional Chinese medicine composition for preventing and treating pullorum salmonellosis | |
CN105250460A (en) | Drug composition for treating rabbit diarrhea and preparation methods of drug composition | |
CN104435053A (en) | Composition with effect of preventing multiple infections and preparation method of composition | |
CN108310136A (en) | A kind of feed addictive and preparation method thereof of prevention white diarrhea | |
CN108066224A (en) | A kind of peace stomach ulcer toothpaste and preparation method thereof | |
CN103405365A (en) | TCM-prescription toothpaste | |
CN104435356B (en) | The herbal composite of anti-chicken heat shock | |
CN102771600A (en) | Isatis root tea-substituted beverage for preventing and treating influenza | |
CN103550739B (en) | Traditional Chinese medicinal composition for treating acute enteritis and preparation method of traditional Chinese medicinal composition | |
CN107648392B (en) | Pharmaceutical composition for preventing and treating bee epidemic disease and preparation method thereof | |
CN104473267B (en) | Folium hydrangeae strigosae beverage with oral cavity health function and preparation method thereof | |
CN104435102A (en) | Composition for clearing heat, removing toxicity and protecting liver and preparation method thereof | |
CN1191086C (en) | Medicine for treating cold in summer and autumn | |
CN110025782A (en) | A kind of Chinese medicine composition of helicobacter pylori resistant and preparation method thereof | |
CN104069399A (en) | Herbal decoction for curing indigestion-type halitosis and preparation method of herbal decoction | |
CN104435101A (en) | Composition capable of preventing and treating cold and preparation method of composition | |
CN110237157B (en) | Chinese herbal medicine preparation for treating influenza and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |
|
RJ01 | Rejection of invention patent application after publication |